This website uses cookies to enhance your browsing experience, improve site performance, and gather analytics. By selecting 'Accept,' you consent to these cookies as described in our Privacy Policy.

Logo

Early Surgical Outcomes in the Use of Hybrid Mesh for Incisional Hernia Repair: Results From a Multicenter Italian Study

Sponsored by Azienda Sanitaria Locale Napoli 2 Nord

About this trial

Last updated 2 years ago

Study ID

202318

Status

Completed

Type

Observational

Placebo

No

Accepting

18+ Years
All Sexes

Trial Timing

Ended 3 years ago

What is this trial about?

Background: Ventral hernia repair poses challenges for surgeons due to controversies in approach, patient selection, and mesh selection. The GORE® SYNECOR Intraperitoneal (IP) Biomaterial, a hybrid mesh, aims to balance durability and infection risk. Objective: To analyze extended-term outcomes of using the Intaperitoneal device for ventral and incisional hernia repair. Methods: Retrospective analysis of patients undergoing surgery in eight Italian Surgery Centers, evaluating pIPOM and sIPOM techniques with GORE® SYNECOR IP Biomaterial. Preoperative evaluations included anthropometric measurements, comorbidities, CT scans, and GIQLI assessments. Surgical procedures and interventions were recorded. Postoperative complications, GIQLI changes, cosmesis, hernia recurrence, and mesh bulging were assessed.

What are the participation requirements?

Inclusion Criteria

* age > 18 years

* Clean wounds

* Informed consent

* Patients affected by Incisional and Ventral Hernia

* Elective surgery

* Hernia size between 3 e 10 cm

Exclusion Criteria

* age < 18 years;

* Life expectancy < 24 months (as estimated by the operating surgeon), -

* Pregnancy

* Immunosuppressant therapy within 2 weeks before surgery

* Clean-contaminated and contaminated, dirty wounds

* Cirrhosis